Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Kyriakos Kirou MD

Kyriakos A. Kirou MD

Director, Lupus Nephritis Program, and Co-Chief, Lupus Clinic, Hospital for Special Surgery (HSS); Rheumatologist, New York Presbyterian Hospital (Cornell) and Memorial Sloan Kettering Cancer Center, New York, New York

Dr. Kyriakos A. Kirou is a rheumatologist at Hospital for Special Surgery (HSS) and also serves on the staff of New York Presbyterian Hospital (Cornell) and Memorial Sloan Kettering Cancer Center. He is the director of the Lupus Nephritis Program at HSS and Co-chief of the Lupus Clinic at HSS. He conducts clinical trials in systemic lupus erythematosus (SLE) and lupus nephritis. He also serves as the Principal Investigator (PI) at HSS for the Lupus Clinical Investigators Network (LuCIN). He is also part of the Lupus Nephritis Trials Network (LNTN). He has conducted translational work on the role of Type I IFN in SLE pathogenesis, as a member of Dr Mary Crow’s Lab at HSS. Dr. Kirou is an Associate Professor of Clinical Medicine at Weill Cornell Medicine.

Disclosures

Dr. Kirou participated in the TULIP-2 trial as the PI at HSS.